138 related articles for article (PubMed ID: 35811772)
1. Autoimmune Retinopathy Caused by Anti-Paraneoplastic Antigen MA2: A Case Study.
Fukushima A; Tabuchi H
Case Rep Ophthalmol; 2022; 13(2):419-423. PubMed ID: 35811772
[TBL] [Abstract][Full Text] [Related]
2. PNMA2 forms non-enveloped virus-like capsids that trigger paraneoplastic neurological syndrome.
Xu J; Erlendsson S; Singh M; Regier M; Ibiricu I; Day GS; Piquet AL; Clardy SL; Feschotte C; Briggs JAG; Shepherd JD
bioRxiv; 2023 Feb; ():. PubMed ID: 36798413
[TBL] [Abstract][Full Text] [Related]
3. PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome.
Xu J; Erlendsson S; Singh M; Holling GA; Regier M; Ibiricu I; Einstein J; Hantak MP; Day GS; Piquet AL; Smith TL; Clardy SL; Whiteley AM; Feschotte C; Briggs JAG; Shepherd JD
Cell; 2024 Feb; 187(4):831-845.e19. PubMed ID: 38301645
[TBL] [Abstract][Full Text] [Related]
4. Distinct clinical characteristics of paraneoplastic optic neuropathy.
Xu Q; Du W; Zhou H; Zhang X; Liu H; Song H; Wang X; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):797-801. PubMed ID: 30021813
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ma2 antibody encephalitis associated with Sjogren's syndrome.
Chevalier K; Noel N; Benoudiba F; Chrétien P; Hacein-Bey-Abina S; Lambotte O
Rev Med Interne; 2021 Aug; 42(8):575-578. PubMed ID: 34052049
[TBL] [Abstract][Full Text] [Related]
6. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
[TBL] [Abstract][Full Text] [Related]
7. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors.
Cui T; Hurtig M; Elgue G; Li SC; Veronesi G; Essaghir A; Demoulin JB; Pelosi G; Alimohammadi M; Öberg K; Giandomenico V
PLoS One; 2010 Dec; 5(12):e16010. PubMed ID: 21209860
[TBL] [Abstract][Full Text] [Related]
10. Anti-ma2 paraneoplastic encephalitis in association with recurrent cervical cancer.
Ney DE; Messersmith W; Behbakht K
J Clin Neurol; 2014 Jul; 10(3):262-6. PubMed ID: 25045381
[TBL] [Abstract][Full Text] [Related]
11. Anti-Ma2 antibody related paraneoplastic limbic/brain stem encephalitis associated with breast cancer expressing Ma1, Ma2, and Ma3 mRNAs.
Sahashi K; Sakai K; Mano K; Hirose G
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1332-5. PubMed ID: 12933950
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated retinopathy after anti-programmed death 1 (PD-1) antibody for treating hepatocellular carcinoma--a case report of a Chinese patient.
Chen Q; Feng C; Sun C; Wang W; Wang M; Chen L; Sun X; Tian G
Am J Ophthalmol Case Rep; 2022 Mar; 25():101370. PubMed ID: 35243142
[TBL] [Abstract][Full Text] [Related]
13. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
[TBL] [Abstract][Full Text] [Related]
14. Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report.
Inui R; Saito K; Shimomura Y; Yamashita D; Kawamoto M; Ishikawa T
BMC Neurol; 2020 Sep; 20(1):355. PubMed ID: 32967629
[TBL] [Abstract][Full Text] [Related]
15. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
16. Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy.
Ahn SJ; Lee HS; Lee WJ; Chu K
Encephalitis; 2021 Jul; 1(3):79-84. PubMed ID: 37469846
[TBL] [Abstract][Full Text] [Related]
17. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
18. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
Khan N; Huang JJ; Foster CS
Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
[TBL] [Abstract][Full Text] [Related]
19. [Severe visual loss caused by autoimmune retinopathy].
ten Berge JC; Schreurs MW; Dufour-van den Goorbergh BC; de Witte PM; van Schooneveld MJ; Rothova A
Ned Tijdschr Geneeskd; 2015; 159():A8039. PubMed ID: 25654680
[TBL] [Abstract][Full Text] [Related]
20. Human paraneoplastic antigen Ma2 (PNMA2) forms icosahedral capsids that can be engineered for mRNA delivery.
Madigan V; Zhang Y; Raghavan R; Wilkinson ME; Faure G; Puccio E; Segel M; Lash B; Macrae RK; Zhang F
Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307812120. PubMed ID: 38437549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
